Nicox (LTS:0RCQ) Total Stockholders Equity : €19.99 Mil (As of Jun. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Nicox Total Stockholders Equity?

Nicox's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €19.99 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Nicox's Book Value per Share for the quarter that ended in Jun. 2024 was €0.32. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Nicox's Debt-to-Equity for the quarter that ended in Jun. 2024 was 1.19.

Nicox Total Stockholders Equity Historical Data

The historical data trend for Nicox's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nicox Total Stockholders Equity Chart

Nicox Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

109.30

100.84

75.55

42.29

21.41

Nicox Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial															60.70	42.29	45.53	21.41	19.99

Nicox (LTS:0RCQ) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Nicox's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(19.988	-	0)	/	63.1435
	=	0.32

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Nicox's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.678	+	20.013)	/	19.988
	=	1.19

Nicox Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Nicox's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nicox Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nicox SA (LTS:0RCQ) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

NICXF:USA ALCOX:France NXOA:Germany NXOA:Germany

Address

Rue Evariste Galois, Emerald Square, Batiment C, Sundesk Sophia Antipolis, Biot, FRA, 06410

Website

https://www.nicox.com

Nicox SA is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health. Its lead program in clinical development is NCX 470 (bimatoprost grenod), a novel nitric oxide-donating bimatoprost eye drop, for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company also has a preclinical research program on NCX 1728, a nitric oxide-donating phosphodiesterase-5 inhibitor, with Glaukos. Its first product, VYZULTA in glaucoma, licensed exclusively worldwide to Bausch + Lomb, is available commercially in the U.S. and over 15 other territories. Nicox generates revenue from ZERVIATE in allergic conjunctivitis, licensed in multiple geographies.

Nicox Headlines

No Headlines